Neuroprotective Pathways and Synaptic Restoration: Molecular Insights into Neuron–Glia Crosstalk and Oxidative Stress Modulation

The dynamic communication between neurons and glial cells forms the molecular foundation of brain homeostasis, synaptic maintenance, and resilience to injury. Disturbances in this neuron–glia dialogue underlie many neurodegenerative disorders, where oxidative stress, mitochondrial dysfunction, and neuroinflammation converge to promote neuronal loss. The present study investigates the cellular and molecular mechanisms governing neuron–glia crosstalk under oxidative challenge, focusing on Nrf2-mediated antioxidant signaling, mitochondrial dynamics, and synaptic restoration.

Primary cortical neuron–astrocyte co-cultures were subjected to controlled oxidative stress using hydrogen peroxide (H₂O₂, 100 µM) for 24 hours, followed by treatment with Nrf2 activators (sulforaphane and curcumin). Cellular responses were assessed through RT-qPCR, Western blotting, confocal immunofluorescence, and targeted proteomic analysis. Oxidative insult significantly reduced neuronal viability (by 43%), disrupted mitochondrial membrane potential, and decreased expression of synaptic proteins (PSD-95, synaptophysin). Post-treatment, a robust activation of the Nrf2–ARE pathway was observed, with a 3–5-fold increase in antioxidant gene expression (HO-1, NQO1, and SOD2) and partial recovery of synaptic protein levels. Astrocyte-conditioned media from treated cultures enhanced neuronal survival by upregulating glutamate transporters (EAAT1/2) and reducing lipid peroxidation markers (MDA, 42% reduction). Furthermore, transmission electron microscopy revealed restoration of mitochondrial integrity and reduction in reactive astrocytosis.

These findings demonstrate that activation of Nrf2 signaling and glial antioxidant responses confer significant neuroprotection against oxidative damage. The study emphasizes the crucial role of astrocytes as metabolic and redox regulators, capable of restoring neuronal function and synaptic plasticity. Targeting the neuron–glia metabolic axis thus represents a promising therapeutic approach to mitigate oxidative neurotoxicity and promote neuroregeneration in disorders such as Alzheimer’s disease, Parkinson’s disease, and cerebral ischemia.